Newest Issue is Out. Get your exclusive copy today.
Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Saudi Arabian Logistics Company SAL Saudi Arabias leading cargo ground handler and logistics provider is pleased to announce the unveiling of its new pharma and perishable facilities at the Cargo Village in Riyadh specializing in perishables and all...
Eppendorf offers now a further building block in supporting scientists with tailored solutions for the daily lab routine Controlled and reliable cell thawing is mandatory for further downstream experiments in every cell handling lab Although waterbat...
Rhythm Pharmaceuticals Inc a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity announced that the US Food Drug Administration FDA has approved IMCIVREE setmelanotide for...
Golden Biotechnology CorpGoldenBiotech TWO a leading Taiwanese biopharmaceutical company announces that its new drug Antroquinonol HOCENA outperforms the other listing drugs for the treatment of relapsed AML acute myeloid leukemia patients in its Pha...
Protalix BioTherapeutics Inc a biopharmaceutical company focused on the development production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx plant cellbased protein expression system and Chiesi Global...
Astellas Pharma Incand FibroGen Inc announced that Japans Ministry of Health Labour and Welfare MHLW approved EVRENZO roxadustat for the treatment of anemia of chronic kidney disease CKD in adult patients not on dialysis
PostEra a biotechnology company offering medicinal chemistry powered by machine learning today announced a collaboration with NeuroLucent a Chicagobased company focused on developing novel treatments for Alzheimers disease and other dementias The fai...
BioNTech SE and Shanghai Fosun Pharmaceutical Group Co Ltd Fosun Pharma Stock Code SH HK jointly announced that their lead mRNA candidate COVID vaccine BNTb will conduct phase clinical trial in Taizhou and Lianshui Jiangsu Province China The phase...
RhoVac a clinical stage company today announced that the American FDA has granted Fast Track Designation to the companys drug candidate RV Fast Track Designation is granted to investigational drugs for expedited review by the FDA to facilitate develo...
Polaryx Therapeutics Inc a biotech company developing small molecule therapeutics for lysosomal storage disorders announced today that it has received from the US Food and Drug Administration FDA both Rare Pediatric Disease and Orphan Drug designatio...
ISD Immunotech ISD which is developing targeted therapies for severe autoimmune diseases announces it has entered into a strategic research collaboration with Biogen Inc Cambridge MA USA
Panaxia Global the controlling owner of Panaxia Labs Israel Ltd Panaxia Israel TASE PNAX Israels largest manufacturer of medical cannabis products and its partner Neuraxpharm Europes leading pharmaceutical company specialized in the central nervous s...
CytoDyn Inc a latestage biotechnology company developing Vyrologix leronlimabPRO a CCR antagonist with the potential for multiple therapeutic indications announced today it signed an agreement with amfAR
ARCA biopharma Inc a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases announced that the US Food and Drug Administration FDA has designated as a Fast Track devel...
Roche announced that the US Food and Drug Administration FDA has approved a supplemental New Drug Application sNDA for Xofluza baloxavir marboxil as a treatment to prevent influenza in people years of age and older following contact with someone wit...
The National Medical Products Administration NMPA has approved a dosing label update in China for AstraZenecas Lokelma sodium zirconium cyclosilicate to include patients with hyperkalaemia on chronic haemodialysis The approval by the NMPA was based o...
Bristol Myers Squibb announced that the European Commission EC has approved Opdivo nivolumab for the treatment of adults with unresectable advanced recurrent or metastatic esophageal squamous cell carcinoma ESCC after prior fluoropyrimidine and plati...
Glycostem Therapeutics BV a leading clinicalstage company focused on the development of therapeutic offtheshelf Natural Killer NK cells today announced the opening of a phase IIIa trial for its lead product oNKord for the treatment of AML patients
Positive highlevel results from an interim analysis of clinical trials of AZD in the UK and Brazil showed the vaccine was highly effective in preventing COVID the primary endpoint and no hospitalisations or severe cases of the disease were reported i...
Through an innovative sterilization freezedrying processes RD laboratory Telstar offers pharmaceutical companies located in China a qualified and complete consultancy service for the development qualification and validation of process cycles simplif...
Ascentage Pharma HK a globally focused clinicalstage biotechnology company engaged in developing novel therapies for cancers chronic hepatitis B CHB and agerelated diseases today announced that the Center for Drug Evaluation CDE of China National Med...
South Korean biotechnology company YBiologics and French pharmaceutical company Pierre Fabre are planning a strategic partnership to explore cancer immunotherapies The announcement took the form of a written letter of intent signed by both parties Th...
Today the US Food and Drug Administration expanded the approved indication for Xofluza baloxavir marboxil to include postexposure prevention of influenza flu for patients years of age and older after contact with an individual who has the flu
Today the US Food and Drug Administration approved Oxlumo lumasiran as the first treatment for primary hyperoxaluria type PH a rare genetic disorder This approval is a cumulation of the work of experts and community members coordinated by the Oxalos...
Viatris Inca new kind of healthcare company today announced tentative approval from the US Food and Drug Administration FDA for a New Drug Application for pediatric dolutegravir tablets for oral suspension mg
The European Commission EC has approved MenQuadfi for active immunization of individuals from the age of months and older against invasive meningococcal disease caused by Neisseria meningitidis serogroups A C W and Y
GlaxoSmithKline plc announced that patient dosing has begun in a phase clinical programme investigating the safety and efficacy of its Respiratory Syncytial Virus RSV candidate vaccine for maternal immunisation GSKA following presentation of positiv...
Merck known as MSD outside the United States and Canada and OncoImmune a privatelyheld clinicalstage biopharmaceutical company today announced that the companies have entered into a definitive agreement pursuant to which Merck through a subsidiary w...
Merck known as MSD outside the United States and Canada today announced the company has submitted applications to the US Food and Drug Administration FDA and European Medicines Agency EMA for licensure of V Mercks investigational valent pneumococcal...
Pfizer Inc today announced that the first participant has been dosed in the Phase BASIS study of marstacimab PF an antitissue factor pathway inhibitor antiTFPI being evaluated for the treatment of people with severe hemophilia A or B with or without...
